title: Letter to the Editor regarding the article by R. Casciaro et al. titled: 'Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: case report and review of literature'.
authors.forename: Anna
authors.initials: A
authors.lastname: Katelari
authors.forename: Argyri
authors.initials: A
authors.lastname: Petrocheilou
authors.forename: Stavros
authors.initials: S
authors.lastname: Doudounakis
authors.forename: Athanasios
authors.initials: A
authors.lastname: Kaditis
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy*; D001232:Aspergillus fumigatus / Q000187:drug effects*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D008297:Male
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B